We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Riverfort Global Opportunities Plc | LSE:RGO | London | Ordinary Share | GB00BKKD0862 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.22 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Crude Petroleum & Natural Gs | -134k | -866k | -0.0011 | -2.00 | 1.71M |
Date | Subject | Author | Discuss |
---|---|---|---|
12/4/2021 14:20 | A close at 2.20p or higher would be good. | red army | |
12/4/2021 11:52 | Nice bit of volume today. DC | daicaprice | |
06/4/2021 09:38 | Everything Pluto has touched is flying, it may take the Pluto listing to see what we’ve got here in them and PIRI. Very happy holding and will add more on weakness. DC | daicaprice | |
31/3/2021 07:15 | good news for RGO as they have warrants on deepverge. Could be worth picking up deepverge shares as well. DeepVerge DVRG the environmental and life science AI company has release a mega RNS today and much more to come. Target by broker in the 80's pence mark, now at 33p and has resistance at 38p and 42p to break first, could test this all today. Incredibly busy period with continued growth across all business divisions: FY 2020 unaudited - organic growth - GBP4.4m FY 2020 aggregated revenues GBP6.1m (unaudited) Dec 2020: Cash & Cash Equivalent GBP2.97m Post Dec 2020: GBP650,740 in exercised warrants FY 2021 guidance remains at GBP10m with GBP3.6m already received in Modern Water orders in Q1 The Labskin Division has sealed its reputation as a leading diagnostics partner with global partners and new service offerings. We work with 18 of the top 20 global pharma companies. Virtual clinical trials with remote collection of human volunteer's skin microbiome. | onehanded | |
31/3/2021 01:11 | 3 v 1 today, blue sky on the way. DC | daicaprice | |
30/3/2021 12:18 | Iii do not allow them. | babbler | |
30/3/2021 12:09 | I am trying to place an order for some of these on III but this is being rejected. Anyone know why? Thanks | cjpaul | |
29/3/2021 12:48 | Thks seraha, much appreciated | dorset64 | |
29/3/2021 12:47 | Try the following link .. | seraha66 | |
29/3/2021 12:43 | seraha66, where do you see this about Pluto's documents for co house? | dorset64 | |
29/3/2021 12:25 | Looks like new document filings for Pluto at Companies House docs being processed and maybe due within the next ten days. Possibly related to the IPO activity. | seraha66 | |
29/3/2021 11:41 | Good buy there . Paying over the offer | jungmana | |
26/3/2021 11:16 | That was some tidy buying before 9am. DC | daicaprice | |
26/3/2021 09:13 | When you do the math's, rgo owns about same share of Pluto as Piri. Rgo own 4.2% of Pluto directly and another 1.2% indirectly due to their 18% shareholding in piri. Both shares today present excellent investment exposure into Pluto | jungmana | |
25/3/2021 09:50 | Welcome Jung | crapcrap | |
25/3/2021 08:40 | Started a position here yesterday with a 200k purchase. Will be adding more when funds available | jungmana | |
24/3/2021 12:53 | Indeed- nice to see both feet over 2 | actybod | |
24/3/2021 10:52 | Looking a bit more like it this morning. DC | daicaprice | |
23/3/2021 08:49 | In my Jarvis a/c through Pello. DC | daicaprice | |
23/3/2021 08:02 | DC I'm confused. How have you managed to purchase Pluto? Thanks Moo | maddymoo | |
22/3/2021 15:10 | Here’s a link to the live OXY-PERP price, I’ve got it in my twitter header. DC | daicaprice | |
22/3/2021 14:46 | No warrants, flat 6p offer. DC | daicaprice | |
22/3/2021 14:11 | daicaprice22 Mar '21 - 11:41 - 210 of 212 0 0 0 Not released yet seraha as far as I’m aware. Oxy-Perp are trading @$3.20 this morning from a 10c purchase price. DC Stunning return - ! | tomboyb |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions